The New Epigenome-Editing Approach for Targeting Dysregulated SNCA Expression: Novel Target Validation for Next-Generation Drug Discovery
Publication
, Conference
Chiba-Falek, O; Tagliafierro, L; Ilich, E; Sriskanda, A; Kantor, B
Published in: MOLECULAR THERAPY
April 22, 2019
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 22, 2019
Volume
27
Issue
4
Start / End Page
35 / 35
Location
Washington, DC
Publisher
CELL PRESS
Conference Name
22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chiba-Falek, O., Tagliafierro, L., Ilich, E., Sriskanda, A., & Kantor, B. (2019). The New Epigenome-Editing Approach for Targeting Dysregulated SNCA Expression: Novel Target Validation for Next-Generation Drug Discovery. In MOLECULAR THERAPY (Vol. 27, pp. 35–35). Washington, DC: CELL PRESS.
Chiba-Falek, Ornit, Lidia Tagliafierro, Ekaterina Ilich, Ahila Sriskanda, and Boris Kantor. “The New Epigenome-Editing Approach for Targeting Dysregulated SNCA Expression: Novel Target Validation for Next-Generation Drug Discovery.” In MOLECULAR THERAPY, 27:35–35. CELL PRESS, 2019.
Chiba-Falek O, Tagliafierro L, Ilich E, Sriskanda A, Kantor B. The New Epigenome-Editing Approach for Targeting Dysregulated SNCA Expression: Novel Target Validation for Next-Generation Drug Discovery. In: MOLECULAR THERAPY. CELL PRESS; 2019. p. 35–35.
Chiba-Falek, Ornit, et al. “The New Epigenome-Editing Approach for Targeting Dysregulated SNCA Expression: Novel Target Validation for Next-Generation Drug Discovery.” MOLECULAR THERAPY, vol. 27, no. 4, CELL PRESS, 2019, pp. 35–35.
Chiba-Falek O, Tagliafierro L, Ilich E, Sriskanda A, Kantor B. The New Epigenome-Editing Approach for Targeting Dysregulated SNCA Expression: Novel Target Validation for Next-Generation Drug Discovery. MOLECULAR THERAPY. CELL PRESS; 2019. p. 35–35.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 22, 2019
Volume
27
Issue
4
Start / End Page
35 / 35
Location
Washington, DC
Publisher
CELL PRESS
Conference Name
22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences